China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
1.610
+0.050 (3.21%)
Aug 13, 2025, 4:00 PM - Market closed
China SXT Pharmaceuticals Employees
China SXT Pharmaceuticals had 75 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
75
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$23,212
Profits / Employee
-$44,049
Market Cap
186.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SXTC News
- 5 months ago - China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency - GlobeNewsWire
- 6 months ago - China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewsWire
- 11 months ago - China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - GlobeNewsWire
- 1 year ago - China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - GlobeNewsWire
- 3 years ago - China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split - GlobeNewsWire
- 3 years ago - China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million - GlobeNewsWire
- 3 years ago - Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC). - Accesswire